The noncalcemic vitamin D analogues EB1089 and 22-oxacalcitriol interact with the vitamin D receptor and suppress parathyroid hormone-related peptide gene expression
- 14 March 1997
- journal article
- Published by Elsevier in Molecular and Cellular Endocrinology
- Vol. 127 (1) , 99-108
- https://doi.org/10.1016/s0303-7207(96)03994-9
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Management of Acute HypercalcemiaNew England Journal of Medicine, 1992
- A G Protein-Linked Receptor for Parathyroid Hormone and Parathyroid Hormone-Related PeptideScience, 1991
- Parathyroid Hormone-Related Protein: Biochemistry and Molecular BiologyCritical Reviews in Biochemistry and Molecular Biology, 1991
- Immunochemical Characterization of Circulating Parathyroid Hormone–Related Protein in Patients with Humoral Hypercalcemia of CancerNew England Journal of Medicine, 1990
- Peptide Mediators of Hypercalcemia in MalignancyAnnual Review of Medicine, 1990
- Humoral Hypercalcemia of CancerNew England Journal of Medicine, 1988
- Parathyroid hormonelike protein from human renal carcinoma cells. Structural and functional homology with parathyroid hormone.Journal of Clinical Investigation, 1987
- Parathyroid hormone-related protein purified from a human lung cancer cell line.Proceedings of the National Academy of Sciences, 1987
- The hypercalcemia of malignancy: Pathogenesis and managementMetabolism, 1982
- Biochemical Evaluation of Patients with Cancer-Associated HypercalcemiaNew England Journal of Medicine, 1980